Inhibits HIV integrase → blocks integration of viral DNA into the host genome.
Clinical Notes
Backbone of first-line ART (usually with two NRTIs) — high resistance barrier, once daily. Weight gain; modest creatinine rise (↓ tubular secretion, not true renal injury); periconception neural-tube-defect signal now considered low risk.